… Molnupiravir has been shown to be effective in preventing hospitalizations and/or clinical …
-moderate COVID-19. In this study, we evaluate the efficacy and safety of molnupiravir in Indian …

… -blind, placebo-controlled study to evaluate viral shedding of SARS-CoV-2 in newly
hospitalized adults to assess the efficacy and safety of molnupiravir for the treatment of COVID-…

… MOVe-IN (protocol MK-4482-001) was a randomized, placebo-controlled, double-blind phase
2/3 trial evaluating safety and efficacy of molnupiravir in hospitalized adults with Covid-19 (…

… There are currently some differences in the research results of molnupiravir. This study
aimed to evaluate the efficacy and safety of molnupiravir in the treatment of COVID-19. …

… of COVID-19. This study evaluates the efficacy and safety of molnupiravir in addition to …
standard-of-care (SOC) for the treatment of non-hospitalized patients with mild COVID-19. …

… (molnupiravir, fluvoxamine and Paxlovid) are effective in reducing the mortality and hospitalization
rates in patients with COVID-19. … bring new hope for COVID-19 recovery and have the …

… In inpatients, molnupiravir may increase mortality by Day 28 … period in COVID-19
inpatients/outpatients treated with molnupiravir … routine use of molnupiravir for COVID-19 treatment …

… between nirmatrelvir/ritonavir and molnupiravir in terms of all-… the two groups in terms of
COVID-19 rebound (OR = 0.87, 95… over molnupiravir in improving clinical efficacy in COVID-19 …

… participants identified in phase 3 of MOVe-OUT, these real-world data align with our
findings and support the use of molnupiravir in immunocompromised patients with COVID-19. …

… suggested that its efficacy was reduced against the omicron variant.Molnupiravir is a course
… Several panellists who voted to recommend molnupiravir added qualifications and caveats …